RE: R.I.P Mhealth It will be a year they officially launch their product VV, so I think it is normal that it is not much income to 31 September 2012. By cons they will show a steady growth rate of acceptance by physicians of VV in the coming months because otherwise the title will not last long indeed. They used $ 154,000 of the 1 million margin secured by all assets. The action is the same price as before acceptance by the FDA but with more income potential in the short term. Why mHealth Division will be dead when at September 31, 2012 it had provided 75% of revenue last quarter (income of 100k). In addition they spent in their financial statements depreciation of $ 1.7 million for the acquisition of the division of mHealth what will that future results will be certainly less negative than those of September 31, 2012.